Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1

Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells

Authors Tahmasebi Mirgani M, Isacchi B, Sadeghizadeh M, Marra F, Bilia AR, Mowla SJ, Najafi F, Babaei E

Received 13 May 2013

Accepted for publication 10 June 2013

Published 13 January 2014 Volume 2014:9(1) Pages 403—417

DOI https://doi.org/10.2147/IJN.S48136

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Maryam Tahmasebi Mirgani,1 Benedetta Isacchi,2 Majid Sadeghizadeh,1,* Fabio Marra,3 Anna Rita Bilia,2,* Seyed Javad Mowla,1 Farhood Najafi,4 Esmael Babaei5

1Department of Genetics, Tarbiat Modares University, Tehran, Iran; 2Department of Chemistry, University of Florence, Sesto Fiorentino, Italy; 3Department of Experimental and Clinical Medicine, University of Florence, Italy; 4Department of Resin and Additives, Institute for Color Science and Technology, Tehran, Iran; 5Department of Biology, University of Tabriz, Tabriz, Iran

*These authors contributed equally to this work

Abstract: Glioblastoma is an invasive tumor of the central nervous system. Tumor recurrence resulting from ineffective current treatments, mainly due to the blood–brain barrier, highlights the need for innovative therapeutic alternatives. The recent availability of nanotechnology represents a novel targeted strategy in cancer therapy. Natural products have received considerable attention for cancer therapy because of general lower side effects. Curcumin is a new candidate for anticancer treatment, but its low bioavailability and water solubility represent the main disadvantages of its use. Here, curcumin was efficiently encapsulated in a nontoxic nanocarrier, termed dendrosome, to overcome these problems. Dendrosomal curcumin was prepared as 142 nm spherical structures with constant physical and chemical stability. The inhibitory role of dendrosomal curcumin on the proliferation of U87MG cells, a cellular model of glioblastoma, was evaluated by considering master genes of pluripotency and regulatory miRNA (microribonucleic acid). Methylthiazol tetrazolium assay and flow cytometry were used to detect the antiproliferative effects of dendrosomal curcumin. Annexin-V-FLUOS and caspase assay were used to quantify apoptosis. Real-time polymerase chain reaction was used to analyze the expression of OCT4 (octamer binding protein 4) gene variants (OCT4A, OCT4B, and OCT4B1), SOX-2 (SRY [sex determining region Y]-box 2), Nanog, and miR-145. Dendrosomal curcumin efficiently suppresses U87MG cells growth with no cytotoxicity related to dendrosome. Additionally, the accumulation of cells in the SubG1 phase was observed in a time- and dose-dependent manner as well as higher rates of apoptosis after dendrosomal curcumin treatment. Conversely, nonneoplastic cells were not affected by this formulation. Dendrosomal curcumin significantly decreased the relative expression of OCT4A, OCT4B1, SOX-2, and Nanog along with noticeable overexpression of miR-145 as the upstream regulator. This suggests that dendrosomal curcumin reduces the proliferation of U87MG cells through the downregulation of OCT4 (octamer binding protein 4) variants and SOX-2 (SRY [sex determining region Y]-box 2) in an miR-145-dependent manner.

Keywords: glioblastoma, pluripotency gene, miRNA, dendrosomal curcumin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K

Neuropsychiatric Disease and Treatment 2014, 10:1793-1798

Published Date: 18 September 2014

Falls and cognitive decline in Mexican Americans 75 years and older

Padubidri A, Al Snih S, Samper-Ternent R, Markides KS, Ottenbacher KJ, Raji MA

Clinical Interventions in Aging 2014, 9:719-726

Published Date: 22 April 2014

Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage

Vadakkan MV, Annapoorna K, Sivakumar KC, Mundayoor S, Kumar GSV

International Journal of Nanomedicine 2013, 8:2871-2885

Published Date: 7 August 2013

Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos

Sharif F, Porta F, Meijer AH, Kros A, Richardson MK

International Journal of Nanomedicine 2012, 7:1875-1890

Published Date: 11 April 2012

Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A

Qi J, Zhuang J, Wu W, Lu Y, Song Y, Zhang Z, Jia J, Ping Q

International Journal of Nanomedicine 2011, 6:985-991

Published Date: 10 May 2011

Synthesis of silver/montmorillonite nanocomposites using γ-irradiation

Kamyar Shameli, Mansor Bin Ahmad, Wan Md Zin Wan Yunus, et al

International Journal of Nanomedicine 2010, 5:1067-1077

Published Date: 1 December 2010